• Oilex 2Q 2018 results commentary

    July 31, 2018 | Posted by

    By Dr Michael Green Oilex has developed a strong position in some highly prospective producing basins in the booming Indian energy market. India relies on imports for something like 80% of its oil needs and LNG imports have doubled. This is despite this country having some highly prospective world-class hydrocarbon basins. Certainly, Oilex is one […]

  • Minoan Group – interim results provide pointer for an imminent re-rate

    July 31, 2018 | Posted by

    Results out this morning from Minoan Group Plc lead us to believe that the end is finally in sight for shareholders of the company re the Travel & Leisure division sale and also that the Cretan development site is about to move into a new stage. Discussions with Chairman Chris Egleton revealed that as per […]

  • Alba Mineral Resources valuation conundrum – part (2)

    July 22, 2018 | Posted by

    We last wrote about Alba Mineral Resources HERE in which we pointed out the monumental valuation disjoint between the market caps of Blue Jay Minerals and Alba which persists to this day. In this blog piece we will now highlight the additional Sum of the Parts (SOTP) discount between UK Oil & Gas (UKOG) and […]

  • Hummingbird Resources 2nd quarter blog comment

    July 19, 2018 | Posted by

    Hummingbird Resources is becoming a successful commercial gold producer. This was demonstrated by Q2 2018 production results today which have really shown that the Yanfolila Gold Mine in Mali is delivering results. Gold production numbers from Yanfolila for the 3 months ended 30 June 2018 cover the first dull quarter of commercial production since the […]

  • Zak Mir interviews Joao Andrade, CEO of Widecells

    July 16, 2018 | Posted by

    Zak Mir interviews Joao Andrade, CEO of Widecells. Click the play button to listen to the audio. https://zakmir.files.wordpress.com/2018/07/joao-widecells_2018-07-16_11-10-58.mp3 Key points discussed: Why are stem cells significant and how is Widecells taking advantage? How competitive is the market for stem cell heath care insurance? In which countries do you see the best growth opportunities? Do you […]